1. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Issue 12 (December 2018) Authors: Kasner, Scott E; Swaminathan, Balakumar; Lavados, Pablo; Sharma, Mukul; Muir, Keith; Veltkamp, Roland; Ameriso, Sebastian F; Endres, Matthias; Lutsep, Helmi; Messé, Steven R; Spence, J David; Nedeltechev, Krassen; Perera, Kanjana; Santo, Gustavo; Olavarria, Veronica; Lindgren, Arne; Bangdiwala, S... Journal: Lancet neurology Issue: Volume 17:Issue 12(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S39 Endogenous circulating BMP9 maintains endothelial barrier function. (December 2018) Authors: Li, W; Long, L; Yang, X; King, R; Southwood, M; Tong, Z; Caruso, P; Upton, PD; Salmon, RM; Condliffe, AM; Nourshargh, S; Chilvers, ER; Morrell, NW Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S84 Identification of MIR-124a as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension. (15th November 2016) Authors: Caruso, P; Dunmore, BJ; Schlosser, K; Schoors, S; Santos, C Dos; Perez-Iratxeta, C; Lavoie, JR; Long, L; Hurst, L; Ormiston, ML; Hata, A; Carmeliet, P; Stewart, DJ; Morrell, NW Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗